Steroid Mistakes Pt. 3 – Labs & Studies

The transcript explains that lab studies are a core part of harm reduction for steroid users. Many complications develop quietly, so waiting for symptoms can mean missing early warning signs. Baseline testing is emphasized, because it helps interpret future changes correctly. Complete blood counts are discussed to track hematocrit and erythrocytosis development. The speaker stresses that you can feel great while numbers are already moving in the wrong direction. Because trends matter, repeating labs on a schedule is treated as more useful than one snapshot. This opening frames monitoring as a practical way to prevent preventable mistakes.

Metabolic and kidney markers are mentioned as ways to follow creatinine and overall function. Liver enzymes are discussed with special attention to oral steroid exposure and hepatic stress. ALT and AST are named as common values that can rise and deserve contextual interpretation. Lipid panels are reviewed, with concerns about HDL suppression and LDL elevation on many compounds. The transcript frames these lipid shifts as meaningful cardiovascular signals over the long term. Hormone related labs like testosterone, estradiol, and SHBG are also referenced for dosing context. The message is that labs should guide understanding, not encourage obsessive number chasing.

The speaker mentions more advanced testing when risk factors justify it. Echocardiograms and coronary calcium scoring are cited as tools to evaluate heart structure and plaque risk. Blood pressure and sleep apnea are tied back to lab abnormalities as modifiable contributors. Lifestyle choices are described as drivers that can worsen numbers even with the same drug dose. The overall goal is preventing mistakes by pairing labs with clinical judgment and good habits. Working with knowledgeable clinicians is recommended so results are interpreted appropriately. The closing reinforces that consistent monitoring supports safer decisions over time.